Longtime readers know I don't like to make bold predictions about the markets or the economy.

For the most part, grand calls are useless.

I've seen far too many people trust these outlandish predictions only for them not to work out. The average person will end up losing money. And the expert who made the prediction will just move on to their next big marketing pitch.

I, instead, want to position my portfolio for just about every outcome... Don't time. Tilt.

This is a phrase I use often. In other words, don't try to time big market moves with an "all or nothing" decision. Simply adjust your allocations. It's that easy.

With that said, while I typically stay away from big predictions, I did go on record with a bold call back in 2022. I warned readers about the death of the "60/40" portfolio.

You've probably heard about the 60/40 allocation for your entire adult life: Put 60% of your investment portfolio in stocks and the other 40% in bonds.

In normal market conditions, that traditional allocation works great. The stocks provide growth but greater risk, and they're balanced against the safety of modest, predictable bond yields.

But sometimes, this rigid model is a disaster for your retirement... You could spend a lifetime squirreling away your savings in a 60/40 allocation, only to come up short if the markets turn against you just before you retire.

As you can see below, the 60/40 portfolio has experienced several "lost decades" since 1900.

You can do better.

That's why my team and I created the Intelligent Retirement model.

This proprietary tool identifies the ideal asset allocation for every market condition. Sometimes, the models call for a higher percentage of gold as protection from volatility. Other times, it calls for a higher percentage of your portfolio in real estate investment trusts ("REITs") to hedge against inflation.

The ideal allocation depends entirely on outside market factors. And those change all the time.

So we designed our model to be flexible – ready for inflation, recessions, bull markets, stagflation, deflation... everything. At the same time, we designed it to still do well in bull markets, so we're not sacrificing outsized stock returns.

We update our allocations every quarter to adjust to what the market is showing us. And so far, my crusade against the traditional 60/40 portfolio has paid off...

Since 2021, our model has returned more than 49%, while the 60/40 portfolio has returned 36%. That's a difference of 13 percentage points. And this outperformance is nothing new, either.

As you can see below, our model has beat the classic method for years...

Right now, our model has most of its portfolio in stocks. But it's also keeping us diversified among other asset classes like REITs, gold, and corporate bonds.

Diversification is the key to managing volatile markets. But again, situations change, so you don't just want to hold defensive positions like bonds in a ripping stock market.

You need to be intelligent about the risks of what comes next... and find the right times to own the right assets to maximize your gains. Our Intelligent Retirement model helps you do that.

Existing Income Intelligence subscribers can view our current allocations here.

And if you want to learn how to manage your allocations better for retirement but aren't subscribed to Income Intelligence yet, you can click here to learn more.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
April 15, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top